Evidence map›Paper›PMID 42146370›Full record

ArticlebioRxiv : the preprint server for biology2026

Large-Scale Assessment of

Sung Yun Jung, Aylar Babaei, Alexandros Tzatsos, Junfeng Ma, Yang Yu, Wai Chin Chong, Huizhen Zhang, Richard T Graham, Conrad Russell Cruz, Javad Nazarian and 3 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sung Yun JungDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Aylar BabaeiCenter for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Alexandros TzatsosDepartment of Anatomy and Cell Biology, George Washington University Cancer Center, Washington, DC, USA.
Junfeng MaDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Georgetown University, Washington, DC, USA.
Yang YuCenter for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Wai Chin ChongCenter for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Huizhen ZhangCenter for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Richard T GrahamDivision of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Conrad Russell CruzCenter for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Javad NazarianDIPG/DMG Center Zurich, Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
Brian R RoodCenter for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Jianhua YangCenter for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Chunchao ZhangDepartment of Otorhinolaryngology - Head and Neck Surgery, The University of Maryland School of Medicine, Baltimore, MD, USA.

Funding

CAMKV Kinase Signaling in NeuroblastomaR01NS118008 · NINDS · CHILDREN'S RESEARCH INSTITUTE · PI YANG, JIANHUA · 2020 to 2024
$2.2M
NINDS NIH HHS R01 NS118008
6 · The paper itself

Abstract

Neoantigens are cancer-specific antigens arising from genomic alterations. Single Amino Acid Variants (SAAVs) represent a primary class of these neoantigens. To evaluate the therapeutic potential of Neurofibromin 1 (

Indexed as

HLA binding predictionNeoantigenNeurofibromatosis Type 1

Identifiers

PMID42146370
PMCPMC13175214

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.